Stadol Addiction and Detoxification

Posed to be a less harmful prescription drug, Stadol NS (butorphanol), a nasal spray, form of painkiller, in reality, has been exposed to be the cause for several deaths. The FDA has logged a significant amount of deaths and severe addictions report associated with Stadol. The spray has been linked to hundreds of cases of addiction and numerous deaths.

Expressed as Tartrate salt, the nasal spray contains a composition of Butorphanol tartrate, a crystalline substance. One milligram of the salt is equivalent to 0.68 mg of the free base. The n-octanol/aqueous buffer partition coefficient of butorphanol is 180:1 at pH 7.5.

The Stadol Injection, USP, is a sterile, parenteral, aqueous solution of butorphanol tartrate for intravenous or intramuscularly administration. In addition to 1 or 2 mg of butorphanol tartrate, each mL of solution contains 3.3 mg of citric acid, 6.4 mg sodium citrate, and 6.4 mg sodium chloride, and 0.1 mg benzethonium chloride (in multiple dose vial only) and a preservative.

STADOL NS is an aqueous solution of butorphanol tartate for administration as a metered spray to the nasal mucosa. Each bottle of STADOL NS contains 2.5 ml of a 10 mg/ml solution of butorphanol tartate with sodium chloride, citric acid, and benzethonium chloride in purified water with sodium hydroxide and/or hydrochloric acid added to adjust the pH to 5.0.

The nasal spray is a pain reliever for moderate or severe pain. The patient is put under butorphanol dose every 3-4 hours either as a nasal sprays or injected into the buttock or hip muscle or into a vein. Typically prescribed for patients recovering from surgery, or migraine headaches the nasal spray works by binding to the pain receptors in the brain.

Factors to be considered before taking the dose are age, body weight, physical status, and underlying pathological condition, use of other drugs, type of anesthesia to be used, and surgical procedure involved. Use in the elderly, patients with hepatic or renal disease or in labor requires extra caution.

Associated with occurrence of abuse and dependence with most reports involving outpatient treatment of chronic painful conditions, Butorphanol tartrate can be life threatening. People may experience asthenia/lethargy, headache, sensation of heat, dry mouth, nausea and/or vomiting stomach pain, anxiety, dizziness, insomnia, nervousness, cough, nasal congestion and/or irritation, sweating, blurred vision, ear pain, and tinnitus (ringing in ears).